Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Meda Acquires Valeant Business in Europe | Contract Pharma

What are you searching for?

Sign in
Breaking News

Meda Acquires Valeant Business in Europe

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Meda has signed an agreement to acquire Valeant’s pharmaceutical business in western and eastern Europe. The acquisition will give Meda an entry into the Russian market. In Eastern Europe, it means a potential for significant market synergies with products in Meda’s existing pipeline, according to the company. In western Europe, Meda’s position will be strengthened, especially in the UK. The majority of the acquired products are also within Meda’s key therapy areas; neurology and dermatology, in line with the company’s focused approach.

The total sales of the acquired business is $181 million, of which Eastern Europe account for $33 million. The major markets are Germany, UK, Italy, Spain and Russia. Total headcount is 380 employees, of which 230 employees in marketing and sales primarily visit specialists within dermatology and neurology.

“I’m really glad that we have reached this deal with Valeant. This acquisition has a perfect fit with our operations in Europe. It also makes a very important contribution to our strategy to become stronger in eastern Europe. We now get a foothold in Russia and we will use that platform to introduce many of our pipeline products. We also look forward to a long term collaboration in other areas with Valeant,” said Anders Lonner, Meda’s chief executive officer.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters